Phio Pharma Corp Live Stock Price Today, Share Analysis and Chart

Name: Phio Pharmaceuticals Corp: Is Infosys Ltd. worth buying?
Item: Phio Pharmaceuticals Corp
Rating: 1.05891675
Author: Trendlyne DVM scores

about

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that...

1.05 0.03 (2.94%)

89.27% Fall from 52W High

301.2K

XNAS Volume

XNAS 31 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

12.7 / 100

Technically Bearish

29.7 / 100

No estimates available

Phio Pharma Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phio Pharma Corp Live Stock Price Today, Share Analysis and Chart

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that...

89.27% Fall from 52W High

SWOT Analysis

Phio Pharma Corp Live Price Chart